A. Lockinger et al., Protection against gas exchange abnormalities by pre-aerosolized PGE(1), iloprost and nitroprusside in lung ischemia-reperfusion, TRANSPLANT, 71(2), 2001, pp. 185-193
Background. Development of severe gas exchange abnormalities and respirator
y failure is a major threat in lung transplantation.
Methods, We used a model of ischemia-reperfusion injury in buffer-perfused
rabbit lungs, with gas exchange conditions being analyzed in detail by the
multiple inert gas elimination technique. A total of 150 min of warm ischem
ia was performed, and anoxic ventilation and a positive intravascular press
ure were maintained throughout the ischemic period.
Results. Reperfusion provoked a transient, mostly precapillary pulmonary ar
tery pressure elevation and progressive lung edema formation attributable t
o increased capillary permeability. Severe ventilation-perfusion mismatch w
ith predominance of shunt flow became apparent within minutes after onset o
f reperfusion, 5 min-aerosolization maneuvers for alveolar deposition of pr
ostaglandin E-1, the long-acting prostacyclin analogue iloprost or the nitr
ic oxide donor agent sodium nitroprusside were undertaken at the onset of i
schemia, All preaerosolized vasodilator agents markedly reduced the pulmona
ry artery pressure elevation and the leakage response upon reperfusion, Mos
t impressively, maintenance of physiological ventilation-perfusion matching
was achieved by these maneuvers, and the development of shunt flow was lar
gely suppressed.
Conclusions. Preischemic alveolar deposition of PGE(1), iloprost, and sodiu
m nitroprusside by aerosol technique is highly effective in conserving norm
al pulmonary hemodynamics, microvascular integrity, and physiological gas e
xchange conditions upon reperfusion. This approach may offer as new strateg
y for maintenace of pulmonary function in lung transplantation.